BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 17786704)

  • 1. Dendritic cells and acute graft-versus-host disease after allogeneic stem cell transplantation.
    Mohty M
    Leuk Lymphoma; 2007 Sep; 48(9):1696-701. PubMed ID: 17786704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory cytokines and dendritic cells in acute graft-versus-host disease after allogeneic stem cell transplantation.
    Mohty M; Gaugler B
    Cytokine Growth Factor Rev; 2008 Feb; 19(1):53-63. PubMed ID: 18083060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the IL17 pathway for the prevention of graft-versus-host disease.
    van der Waart AB; van der Velden WJ; Blijlevens NM; Dolstra H
    Biol Blood Marrow Transplant; 2014 Jun; 20(6):752-9. PubMed ID: 24565991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
    Talmadge JE
    Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
    Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
    Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of purine analogues in low-intensity regimens with allogeneic hematopoietic stem cell transplantation.
    Foss FM
    Semin Hematol; 2006 Apr; 43(2 Suppl 2):S35-43. PubMed ID: 16549113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of cytokines in the pathophysiology of acute graft-versus-host disease (GVHD): are serum/plasma cytokines potential biomarkers for diagnosis of acute GVHD following allogeneic hematopoietic cell transplantation (Allo-HCT)?
    Toubai T; Tanaka J; Paczesny S; Shono Y; Reddy P; Imamura M
    Curr Stem Cell Res Ther; 2012 May; 7(3):229-39. PubMed ID: 22023620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A subset of CD8+ T cells acquiring selective suppressive properties may play a role in GvHD management.
    Avivi I; Stroopinsky D; Rowe JM; Katz T
    Transpl Immunol; 2013 Jan; 28(1):57-61. PubMed ID: 23196257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced intensity conditioning for allogeneic hematopoietic stem-cell transplant determines the kinetics of acute graft-versus-host disease.
    Turner BE; Kambouris ME; Sinfield L; Lange J; Burns AM; Lourie R; Atkinson K; Hart DN; Munster DJ; Rice AM
    Transplantation; 2008 Oct; 86(7):968-76. PubMed ID: 18852664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8+ T cell dose affects development of acute graft-vs-host disease following reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation.
    Mohty M; Bagattini S; Chabannon C; Faucher C; Bardou VJ; Bilger K; Vey N; Gaugler B; Stoppa AM; Coso D; Ladaique P; Olive D; Viens P; Blaise D
    Exp Hematol; 2004 Nov; 32(11):1097-102. PubMed ID: 15539088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo dynamics of T cells and their interactions with dendritic cells in mouse cutaneous graft-versus-host disease.
    Morin-Zorman S; Wysocki C; Zhu J; Li H; Zorman S; Matte-Martone C; Kisanga E; McNiff J; Jain D; Gonzalez D; Rothstein DM; Lakkis FG; Haberman A; Shlomchik WD
    Blood Adv; 2019 Jul; 3(14):2082-2092. PubMed ID: 31296496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
    Pérez-Simón JA; Díez-Campelo M; Martino R; Brunet S; Urbano A; Caballero MD; de León A; Valcárcel D; Carreras E; del Cañizo MC; López-Fidalgo J; Sierra J; San Miguel JF
    Br J Haematol; 2005 Aug; 130(3):394-403. PubMed ID: 16042689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of host dendritic cells after transplantation is associated with graft-versus-host disease.
    Chan GW; Gorgun G; Miller KB; Foss FM
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):170-6. PubMed ID: 12652467
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Reconstitution kinetics of dendritic cells following allogeneic hematopoietic stem cell transplantation].
    Fu HX; Zhang XH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):222-6. PubMed ID: 18315936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience.
    Strullu M; Rialland F; Cahu X; Brissot E; Corradini N; Thomas C; Blin N; Rialland X; Méchinaud F; Mohty M
    Eur J Haematol; 2012 Jun; 88(6):504-9. PubMed ID: 22372430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells in allogeneic hematopoietic stem cell transplantation.
    Nachbaur D; Kircher B
    Leuk Lymphoma; 2005 Oct; 46(10):1387-96. PubMed ID: 16194884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
    Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host-derived CD8⁺ dendritic cells protect against acute graft-versus-host disease after experimental allogeneic bone marrow transplantation.
    Weber M; Rudolph B; Stein P; Yogev N; Bosmann M; Schild H; Radsak MP
    Biol Blood Marrow Transplant; 2014 Nov; 20(11):1696-704. PubMed ID: 25132527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.